Media Releases 2012
You are not authorised to view this resource.
You need to login.
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email:
More about our Projects
NeuroNova’s business strategy centers on developing novel therapeutic products based on neurogenesis in areas of high unmet medical need in neurodegenerative diseases.
More about business development.